You searched for Humanized antibody - Page 13 of 44

Regeneron Sanofi dupilumab Atopic Dermatitis

News and Trends 29 Mar 2017

Get Ready for One of the Biggest New Drug Approvals of the Year

…such as those implicated in atopic dermatitis, asthma and allergies. The antibody represents the first drug targeting the IL-4/IL-13 pathways. The antibody is indicated for the treatment of moderate to…

March 29, 2017 - 3 minutesmins - By Melanie De Almeida

Best in Biotech 30 Jun 2023

Five biotech companies making a name for themselves in Vancouver

…antibody therapy treatment for COVID-19, when, in 2021, bamlanivimab, used together with etesevimab, became the first monoclonal antibody medicine for COVID-19 to receive U.S. Food and Drug Administration (FDA) Emergency…

June 30, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 22 Jun 2023

Alchemab Therapeutics unveils Alzheimer’s candidate

Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, has unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate, at the Antibody Industrial Symposium…

June 22, 2023 - 3 minutesmins - By Jim Cornall

Innate Pharma Cancer immunotherapy header

News and Trends 22 Oct 2018

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold

…cancer patients that is very hard to treat. A checkpoint inhibitor antibody In the Phase II trial, Innate’s checkpoint inhibitor antibody was part of a combination therapy. While…

October 22, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 7 Jun 2017

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

…competitors, BMS, MSD and Roche, in the coveted PD-L1 / PD-1 checkpoint inhibitor space. The Danish antibody giant Genmab presented a Phase I/IIa update on HuMax-AXL-ADC, an antibody-drug conjugate (ADC)…

June 7, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

samsung bioepis imraldi humira adalimumab biosimilar tnf a

News and Trends 28 Aug 2017

Samsung Bioepis Gets European Approval for Biosimilar of Best-Selling Antibody

…anti-TNF-α antibody launched by Samsung Bioepis, making it the first company with biosimilars of all blockbusters that that target TNF-α. The other two are Benepali, a biosimilar of Amgen and…

August 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 11 Jan 2024

Ten NK cell therapy companies to look out for this year

…therapy that is designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of monoclonal antibodies. This way, the drug can kill auto-antibody producing B cells. The candidate is also being…

January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter

In Depth 31 Jan 2017

Biologicals on the Brain: Biotech in Neurodegenerative Disease

…long anticipated Alzheimer’s antibody, failed in their third attempt at a late stage trial last year, it crushed patients’ hopes and raised doubts about whether or not targeting amyloid-beta plaques,…

January 31, 2017 - 7 minutesmins - By Diana Kwon

Numab Ono Pharmaceutical Immuno Oncology

News and Trends 28 Mar 2017

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

…a plug-and-play platform to rapidly develop combinations of several antibody fragments into a single agent with a completely novel mechanism of action. Numab’s multi-specific antibody The potential of…

March 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 30 May 2024

Covalent biologics: a new class of drugs on the horizon

…American company Enlaza Therapeutics’ undisclosed preclinical pipeline is mainly focused on antibody drug conjugates (ADCs). These drugs consist of an antibody that attaches to cancer cell targets, a chemotherapy drug…

May 30, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 13 Feb 2020

French Partnership Deploys AI for Antibody Drug Discovery

French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence. The three-year partnership will use artificial intelligence, or AI, in…

February 13, 2020 - 2 minutesmins - By External Contributor

Ulrich dauer vivoryon alzheimers disease

Interview 23 Nov 2022

What recent mixed clinical results can teach about Alzheimer’s disease

…Abeta. Varoglutamstat also blocks the pathology earlier in the process than leading antibody candidates, and can be taken orally — a more convenient drug delivery than injecting or infusing antibody…

November 23, 2022 - 7 minutesmins - By Jonathan Smith

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Get Ready for One of the Biggest New Drug Approvals of the Year

Five biotech companies making a name for themselves in Vancouver

Alchemab Therapeutics unveils Alzheimer’s candidate

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

Samsung Bioepis Gets European Approval for Biosimilar of Best-Selling Antibody

Ten NK cell therapy companies to look out for this year

Biologicals on the Brain: Biotech in Neurodegenerative Disease

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

Covalent biologics: a new class of drugs on the horizon

French Partnership Deploys AI for Antibody Drug Discovery

What recent mixed clinical results can teach about Alzheimer’s disease

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!